NCT07320898

Brief Summary

The aim of this study was to evaluate the effect of injectable platelet rich fibrin (i-PRF) injection, in addition to routine root canal treatment, on alkaline phosphatase (ALP) and matrix metalloproteinase-9 (MMP-9) levels in teeth with chronic apical periodontitis. A total of 60 patients were included and randomly divided into two groups: the control group and the experimental group (i-PRF). Gingival crevicular fluid (GCF) samples and periapical exudate (PAE) samples were collected from the teeth at the first appointment, after completion of chemomechanical preparation. In both groups, calcium hydroxide was placed in the root canals, and the teeth were temporarily sealed with composite resin. While no additional procedure was performed in the control group, patients in the experimental group received submucosal i-PRF injection. The second samples were obtained after 4 weeks, and in the same session, the root canal treatment was completed, followed by permanent restoration. ALP and MMP-9 levels in the collected samples were analyzed using the ELISA test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 27, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 6, 2026

Completed
Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

5 months

First QC Date

November 27, 2025

Last Update Submit

March 25, 2026

Conditions

Keywords

apical periodontitisInjectable platelet-rich fibrinAlkaline phosphataseMatrix metalloproteinase-9

Outcome Measures

Primary Outcomes (1)

  • ALP and MMP-9 Levels in Periapical Exudate (PAE) and Gingival Crevicular Fluid (GCF)

    In teeth with apical periodontitis, periapical exudate (PAE) and gingival crevicular fluid (GCF) collected during the first and second sessions of root canal treatment will be analyzed to measure alkaline phosphatase (ALP) and matrix metalloproteinase-9 (MMP-9) levels. ALP levels will be expressed in U/L, while MMP-9 levels will be expressed in ng/dL, and each enzyme will be measured and reported separately. Enzyme levels will be compared between the group receiving injectable platelet-rich fibrin (i-PRF) and the group not receiving i-PRF.

    Baseline and 28. Days

Secondary Outcomes (1)

  • Comparison of ALP and MMP-9 Levels Between Sessions and Sample Types

    Baseline and 28. Days

Study Arms (2)

Control Group

30 participants. Procedure: Root canal treatment without i-PRF application. Collection of GCF and PAE samples.

I-PRF Group

30 participants. Procedure: i-PRF application and root canal treatment. Collection of GCF and PAE samples.

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patients between the ages of 18-64 years old and diagnosed with apical periodontitis who applied to Kırıkkale University, Faculty of Dentistry, Department of Endodontics with the indication of root canal treatment will be included in the study.

You may qualify if:

  • Sixty patients who applied to Kırıkkale University Faculty of Dentistry and were diagnosed with chronic apical periodontitis and were included in the PAI 3-4 groups according to the Periapical Index Scoring System (PAI) among the patients who were prescribed root canal treatment were included in the study.
  • Patients aged 18-64
  • Upper or lower incisors and premolars with primary apical periodontitis
  • Patients with ASA I
  • Patients who have provided written informed consent to participate in the study.

You may not qualify if:

  • Patients with ASA II or higher,
  • Patients who have used antibiotics and anti-inflammatory medications within the last month,
  • Patients with a periodontal pocket greater than 3 mm in the affected tooth,
  • Teeth with internal or external root resorption, or teeth with swelling and pain on palpation,
  • Pregnant women or those suspected of pregnancy,
  • Patients with generalized periodontitis,
  • Patients with immunosuppressive systemic diseases such as diabetes and hepatitis will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kırıkkale University, Faculty of Dentistry

Kırıkkale, Kırıkkale, 71100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Periapical Periodontitis

Condition Hierarchy (Ancestors)

Periapical DiseasesJaw DiseasesStomatognathic DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Study Officials

  • Gamze E NALBANT, Research Assistant

    Kirikkale University Faculty of Dentistry

    PRINCIPAL INVESTIGATOR
  • Ali Türkyılmaz, Associate Professor

    Kirikkale University Faculty of Dentistry

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 27, 2025

First Posted

January 6, 2026

Study Start

January 1, 2025

Primary Completion

June 1, 2025

Study Completion

October 10, 2025

Last Updated

March 31, 2026

Record last verified: 2026-03

Locations